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Abstract 
Introduction. Tetanus, also known as lockjaw, is a very dangerous, infectious, acute, usually 
afebrile disease characterised by muscle spasms. The causative agent of  the disease is 
the bacterium Clostridium tetani. This pathogen produces a specific neurotoxin, termed 
tetanus toxin, with two components: tetanospasmin and tetanolysin. Light chains of  
tetanospasmin cleavage synaptobrevin, which in turn prevent release of  the inhibitory 
neurotransmitter GABA into the synaptic cleft. The α-motor neurons are, therefore, 
under no inhibitory control, as a result of  which they undergo sustained excitatory 
discharge causing the characteristic motor spasms of  tetanus. 
Materials and Methods. In this research, we attempted to normalise disorders caused by 
tetanus toxin by using haloperidol (at doses of  4, 5, 6, 7 and 8 mg/kg b.w.), alone and in 
combination with (-)-nuciferine (at a dose of  5 mg/kg b.w.) or aminooxyacetic acid (at 
a dose of  20 mg/kg b.w.). Experiments were conducted on albino mice. Experimental 
tetanus was induced by application of  tetanus toxin. 
Results and Conclusions. Application of  haloperidol (alone and in combination with 
(-)-nuciferine and aminooxyacetic acid) was carried out 24 h following the application of  
tetanus toxin. It was found that haloperidol, given alone in a dose of  4 mg/kg, prolonged 
the average survival time of  mice with experimental tetanus by 24.35 h compared to the 
control animals. Additionally, the combination of  haloperidol with (-)-nuciferine slightly, 
but non-significantly, extended survival time , while the combination of  haloperidol 
with aminooxyacetic acid produced the best effect on extension of  survival time (mice 
survived on average 27.74 h longer than control mice).
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INTRODUCTION
Tetanus is a very dangerous infectious disease occurring in humans and various animal 
species which characterised by muscle spasms. The causative agent of  the disease 
is Clostridium tetani, a gram positive, anaerobic bacillus. Older or stressed cells of  
Cl. tetani lose their flagella after the development of  spores (Cato et al., 1986). The 
bacteria usually enter the human or animal body through damaged skin (Collee & van 
Heyningen, 1990). 
Cl. tetani produces a specific neurotoxin – tetanus toxin (Atkinson, 2012), which 
consists of  two components: tetanospasmin and tetanolysin (Schiavo et al., 1992). 
Tetanospasmin is responsible for the appearance of  clinical signs of  disease, while the 
function of  tetanolysin is still unknown (Rizwan, 1999). Tetanospasmin consists of  
heavy (H) and light (L) chains (Doussau et al., 1999). The carboxyl terminal portion 
of  the H chain, termed HC, mediates attachment to gangliosides (GD1b and GT1b) 
on peripheral nerves (Li et al., 1994; Collee & van Heyningen, 1990). It is then moved 
from the peripheral to the central nervous system by retrograde axonal transport 
and trans-synaptic spread. The entire toxin molecule is internalised into presynaptic 
cells and, in a process requiring the HN fragment, the L chain is released from the 
endosome. The L chain cleaves synaptobrevin (Schiavo et al., 2000). Synaptobrevin is 
an integral membrane component of  synaptic vesicles and it is essential for the fusion 
of  synaptic vesicles with the presynaptic membrane (Hardman & Limbird, 1996). 
Outside the nervous system, synaptobrevin is found in endocrine cells (Baumert et al., 
1989). Cleavage made by tetanus toxin L chain prevents the release of  their contents, 
i.e. the inhibitory neurotransmitter γ-aminobutyric acid (GABA), into the synaptic 
cleft. The α-motor neurons are, therefore, under no inhibitory control, and thus, they 
undergo sustained excitatory discharge causing the characteristic motor spasms of  
tetanus. The toxin exerts its effects on the spinal cord, the brain stem, peripheral nerves, 
neuromuscular junctions, and directly onto muscles. The extent to which cortical and 
subcortical structures are involved remains unknown. However, it is well known that 
the toxin is a potent convulsant when injected into the cortex of  experimental animals 
(Montecucco & Schiavo, 1994). 
Therefore, in this research, we examined the effect of  haloperidol (a butyrophenone 
neuroleptic), a substance that acts as a tranquillizer, sedative and muscle relaxant and 
its combination with compounds that antagonise the central effects of  tetanus toxin 
on prolonging survival time in mice with experimental tetanus.
MATERIALS AND METHODS
Materials
The study was conducted on albino mice of  both sexes weighing approximately 20-25 
grams (strain Pasteur Institute Novi Sad; bred at the Department of  Pharmacology 
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and Toxicology of  the Veterinary Faculty in Sarajevo). For the purposes of  this study, 
we used a control group (5 animals per group) and experimental groups (10 animals 
per group). The Ethics Committee of  the Veterinary Faculty, Sarajevo, approved 
the research and experimental procedures (Approval No. 1/17, date 20.05.2017). 
The animals were kept in conventional conditions and were treated according to the 
Animal Welfare Regulations. The animals were maintained on standard diet with free 
access to water and housed in groups of  10 mice per cage for seven days prior to the 
experiment. 
Substances used in the study
 – tetanus toxin (Institute of  Immunology, Zagreb, Croatia);
 – haloperidol (Sigma-Aldrich, USA);
 – (-)-nuciferine (Pharmaceutical Research Department, F. Hoffmann-La Roche CO., 
Ltd., Ch-4002 Basel, Switzerland);
 – aminooxyacetic acid (Sigma-Aldrich, USA);
 – water for injection, used to dilute all the above substances.
Methods
Prior to its administration, tetanus toxin was diluted in water for injection and was 
then administered intramuscularly (i.m.) in the m. gastrocnemius of  the mouse’s right 
leg, at a dose of  0.2 µg per animal. We used this dose of  tetanus toxin on the basis of  
previously conducted studies (Hadžović et al., 1975; Muminović, 1983), when it was 
used to determine the period of  time for LD50 of  tetanus toxin for each group. At that 
time, it was established that a dose of  0.2 µg per animal administered i.m. kills 50% of  
experimental animals within 48 hours, while a dose of  0.1 µg per animal kills 50% of  
experimental mice within 7 days. 
Specific doses of  haloperidol, (-)-nuciferine and aminooxyacetic acid, intended for use 
in this study, were established in a preliminary study due to lack of  bibliographic data. 
Consequently, the substances were administered at the following doses: haloperidol 
was administered subcutaneously (s.c.) (at doses of  4, 5, 6, 7 and 8 mg/kg b.w.), whilst 
(-)-nuciferine (at a dose of  5 mg/kg b.w.) and aminooxyacetic acid (at a dose of  20 mg/
kg b.w.) were administered intraperitoneally. These above mentioned substances were 
administered to mice in experimental groups after the occurrence of  local tetanus in 
the right leg, approximately 24 h after administration of  tetanus toxin. The substances 
were administered once per day, which was continued until the animal died. Each 
experimental group had its own control group, with tetanus toxin and the solvent 
(water for injection) administered in an equivalent way as the tetanus toxin/water for 
injection in the experimental mouse groups. 
Basic statistical data diagnostics was conducted by using Microsoft Excel® (Microsoft 
Office package, Microsoft, USA).
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RESULTS AND DISCUSSION
Induction of experimental tetanus:
In animals with no application of  life-extending substances, the first signs of  local 
tetanus in each animal’s right leg were registered 24 h after application of  tetanus toxin. 
The leg was stiff  and extended, and during this period, no death of  experimental 
animals was recorded. In the next 48 h, general tetanus started to develop, followed by 
the animal’s death.
Application of substances:
Effects of  haloperidol (central dopamine receptor antagonist) and its combination with 
(-)-nuciferine (competitive antagonist of  glutamate) and aminooxyacetic acid (inhibits 
4-aminobutyrate aminotransferase or GABA-T activity) on prolonged survival time in 
mice with experimental tetanus are presented in Table 1.
Table 1. Effects of  haloperidol (in different doses), and combination of  haloperidol with 
(-)-nuciferine, as well as combination of  haloperidol with aminooxyacetic acid on the survival 
time of   tetanus toxin-affected mice 
Groups N Substances Doses(µg/kg, b.w.; mg/kg b.w.)
Survival time
(h)






0.2 µg/kg, /b.w. + 4 mg/kg, b.w. 113.55 ± 7.14
0.2 µg/kg, b.w. + 5 mg/kg, b.w. 106.95  ± 6.40
0.2 µg/kg, b.w. + 6 mg/kg, b.w. 102.00  ± 5.06
0.2 µg/kg, b.w. + 7 mg/kg, b.w. 107.85  ± 10.01
























116.94*  ± 7.53
N = number of  animals; b.w. = body weight; *significant
The first part of  the experiment was carried out to determine the effective dose 
of  central dopamine receptor antagonist haloperidol (Table 1). Haloperidol at s.c. 
doses of  5, 6, 7 and 8 mg/kg b.w. did not effectively prolong mouse survival times 
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compared to the control animals. However, a dose of  4 mg/kg b.w. achieved the best 
results, prolonging the average survival time of  the mice to almost 114 h, while the 
average survival time of  control mice was around 89 h (Table 1). Haloperidol leads 
to relaxation of  skeletal muscles from the spasm due to its direct interaction with 
inhibitory transmitter receptors on the body (soma) of  α-motor neurons in the spinal 
cord (Coyne, 2006; Muminović, 1983; Nakamura et al. 2000). Haloperidol also acts as 
a tranquillizer (Maddison et al., 2008), which is very important, especially in tetanus, 
where reactions to external stimuli are extremely strong. 
In order to expand the research, we combined haloperidol with (-)-nuciferine, a 
competitive antagonist of  glutamate (Farkas & Ono, 1995; Roberts & Porter, 1995). Co-
administration of  haloperidol and (-)-nuciferine caused a slight extension of  survival 
time in mice with experimental tetanus (Table 1). However, the applied (-)-nuciferine 
dose of  5 mg/kg b.w. did not give the expected results, so this substance was not 
further used in this study. We had assumed that concomitant use of  haloperidol and 
(-)-nuciferine could lead to summation of  their effects, which was confirmed in our 
research (data not shown). 
We also combined haloperidol with aminooxyacetic acid. This combination produced 
the longest extension of  mice survival time, to around 117 h (Table 1). Aminooxyacetic 
acid inhibits (GABA-T) activity in vitro and in vivo, leading to less ɣ-aminobutyric acid 
(GABA) being broken down. Subsequently, the level of  GABA is increased in tissues 
(Losher et al., 1989; Mujezinović et al., 2011). 
CONCLUSION
In conclusion, haloperidol at a dose of  4 mg/kg b.w. prolonged the average survival 
time of  tetanus toxin-affected mice by 24.35 h compared to the control group of  mice 
with experimental tetanus. However, the application of  higher doses (5, 6, 7 and 8 
mg/kg b.w.) did not produce further increases of  survival time. Co-administration of  
haloperidol with (-)-nuciferine led to a slight extension of  survival time in mice with 
experimental tetanus, whereas the combination of  haloperidol with aminooxyacetic 
acid produced the best effect on the extension of  survival time (mice survived 27.74 
h longer than control mice).
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DELOVANJE HALOPERIDOLA, AMINOOKSISIRĆETNE 
KISELINE I (-)-NUCIFERINA NA PRODUŽENJE 
PREŽIVLJAVANJA MIŠEVA S TETANUSOM
MUJEZINOVIĆ Indira, SMAJLOVIĆ Ahmed, ĆUPIĆ Vitomir
Kratak sadržaj
Uvod. Tetanus  je veoma opasna, akutna, obično afebrilna bolest koju karakteriše mišićni 
spazam. Uzročnik obolenja je bakterija Clostridium tetani, koja proizvodi specifičan 
neurotoksin ili tetanus toksin. Toksin se sastoji od dve komponente: tetanospazmina 
i tetanolizina. Laki lanac tetanospazmina cepa sinaptobrevin, što za posledicu ima 
sprečavanje oslobađanje inhibitornog neurotransmitera GABA u sinaptički procep. 
Funkcija ekscitatornih neurotransmitera ostaje očuvana, te pod njihovim uticajem 
dolazi do grča skeletne muskulature.
Materijali i metode. U ovom istraživanju pokušali smo normalizovati poremećaje 
uzrokovane tetanus toksinom koristeći haloperidol (u dozama od 4, 5, 6, 7 i 8 mg/
kg t.m.), samostalno i u kombinaciji sa (-)-nuciferinom (u dozi od 5 mg/kg t.m.) i 
aminooksirćetnom kiselinom (u dozi od 20 mg/kg t.m.). Kompletno istraživanje je 
sprovedeno na albino miševima. Eksperimentalni tetanus izazvan je aplikacijom tetanus 
toksina.
Rezultati i zaključak. Primena haloperidola (samo i u kombinaciji sa (-)-nuciferinom 
i aminooksirćetnom kiselinom) vršena je 24 sata nakon aplikacije tetanus toksina. 
Haloperidol, aplikovan u dozi od 4 mg/kg t.m., produžio je vreme preživljavanja 
miševa s eksperimentalnim tetanusom za oko 24.35 sati u odnosu na kontrolnu 
grupu životinja, te smo ovu dozu smatrali jedino opravdanom za dalja istraživanja. 
Kombinacija haloperidola s (-)-nuciferinom neznatno produžava vreme preživljavanja, 
dok je kombinacija haloperidola sa aminooksirćetnom kiselinom imala nabolji efekt na 
produženje ovog perioda. Period preživljavanja je produžen oko 27.74 sata u odnosu 
na kontrolnu grupu životinja.
Ključne reči: tetanus, tetanus toksin, haloperidol, (-)-nuciferin, aminooksisirćetna 
kiselina
